Full name
"AVENA SATIVA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | 0,3 | -0 | -108,6 |
Gross profit (loss) | -0,2 | 0,3 | -0 | -110,1 |
EBITDA | -0,2 | 0,1 | -0,2 | -277,4 |
Short time liabilities | 3,8 | 3,8 | 4,1 | 8,3 |
Other operating costs | 0,2 | 0,2 | 0,3 | 61 |
Equity capital | 2,3 | 2,5 | 2,5 | -1,8 |
Operating profit (EBIT) | -0,3 | 0,1 | -0,3 | -334,9 |
Assets | 6,2 | 6,6 | 6,9 | 4,9 |
Net profit (loss) | -0,1 | 0,2 | -0 | -119,5 |
Cash | 0 | 0 | 0 | -30,3 |
Liabilities and provisions for liabilities | 3,9 | 4,1 | 4,4 | 8,9 |
Net income from sale | 18,6 | 20 | 21,5 | 7,7 |
Working assets | 6 | 6,4 | 6,7 | 4,4 |
Other income costs | 0 | 0 | 0 | 2,6 |
Depreciation | 0 | 0 | 0 | 19,9 |
% | % | % | p.p. | |
Profitability of capital | -5,3 | 9,2 | -1,8 | -11 |
Equity capital to total assets | 36,5 | 38 | 35,6 | -2,4 |
Gross profit margin | -1 | 1,7 | -0,2 | -1,9 |
EBITDA Margin | -1,3 | 0,7 | -1,1 | -1,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 74 | 70 | 70 | 0 |
Current financial liquidity indicator | 1.5907200574874878 | 1.6744062900543213 | 1.6141685247421265 | -0,1 |
Net dept to EBITDA | 0.11028764396905899 | -0.2835448980331421 | 0.11140450835227966 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane